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Abstract. The 3 February 1983 and in revised form 18 July 1984. particles were rapidly and substantially converted to low density lipoproteins, suggesting that the major precursor of the latter was to be found in this density range. Whereas only 10% of apolipoprotein B in Sf 100-400 lipoproteins reached the low density lipoprotein flotation range, >40% of Sf 20-100 B protein eventually appeared in Sf 0-12 particles; and when very low density lipoprotein of d < 1.006 kg/liter is used as a tracer of apolipoprotein B metabolism it is primarily this population of small very low density lipoprotein particles in the Sf 12-100 flotation range that is labeled. A detailed examination was made of apolipoprotein B metabolism in three dysbetalipoproteinemic subjects. The heterogeneous, most investigations of their metabolism have, for the sake of simplicity, assumed homogeneity in one or both classes. Initial studies designed to examine the conversion of total VLDL (d < 1.006 kg/liter) to LDL (d < 1.006-1.063 kg/liter) suggested that, at least in normal subjects, there exists a precursor-product relationship between the two (1) . Recent attempts to subfractionate these species have revealed new levels of complexity in this metabolic scheme (2) (3) (4) . In particular, it is now apparent that there is another class of lipoproteins (5, 6) (apoB) in VLDL subsequently appears in the LDL density range, even in normal subjects (6) . In hypertriglyceridemic individuals the situation appears to be more complex still, inasmuch as their LDL is clearly polydisperse both in terms of structure and metabolism (4) .
Several approaches have been made to examine the physicochemical heterogeneity of VLDL. Early chromatographic studies using an agarose gel matrix (7) demonstrated that this class has a particle size range of -300-1,000 A. With decreasing size, the triglyceride content of the particle falls and it becomes relatively enriched in cholesterol and protein, giving rise at the lower end of the spectrum to VLDL with features similar to those of the remnant particles derived by lipolysis of very large intestinal triglyceride-rich chylomicrons (8) . Cumulative flotation ultracentrifugation provides a convenient method for subfractionating VLDL into particles of defined flotation rate (9) . Although the separation here depends primarily on particle density, the resulting fractions are similar to those obtained by agarose gel filtration. Thus, when compared with the largest particles (Sf 100-400), the smaller species (Sf 20-60) are enriched in protein and cholesteryl esters and depleted of triglyceride (10, 11) . In a preliminary study (12) we have used the cumulative flotation procedure to show that the large VLDL of Sf 100-400 is converted stepwise to particles of Sf 20-60, which thereafter transfer to some extent into denser lipoproteins; other workers have usefully employed the technique to demonstrate that both triglyceride and apoB can enter the pathway at several points along its length. For example, Fisher et al. (4) have found that 25-60% of the newly synthesized apoB first appears in the cascade at the level of the small, triglyceride-depleted particle.
In the present study we have examined the metabolic heterogeneity of VLDL in greater detail and have compared our results acquired by the cumulative flotation procedure 1 Experimental protocol. The study was designed to examine the metabolism of apoB in its transit from large (Sf 100-400)2 triglyceriderich VLDL through to LDL (Sf 0-12). The control subjects were examined in three groups (A-C, Table I ). Four volunteers in group A received an intravenous injection of 1251I-VLDL (Sf 100-400); three in group B were given the same material plus a tracer dose of '31I-VLDL (d < 1.006 kg/liter);2 and two in group C received intravenous injections of 125I-VLDL (Sf 40-60) and 131I-VLDL (Sf 20-40) in an attempt to define the events that take place in this narrow density interval. The eight hypertriglyceridemic subjects were studied in two groups. The first of these comprised four Type IV individuals (Table I) who were examined with four control subjects and received a tracer of autologous 125I-VLDL (Sf 100-400). The same lipoprotein fraction was injected into the second group (group D, Table I ) of three Type III and one Type IV hyperlipoproteinemic patients. Simultaneously, two of the former and the Type IV individual were given autologous Sf 20-60 VLDL while the other Type III volunteer received homologous Sf 100-400 VLDL from the Type IV subject.
Lipoprotein isolation techniques. All lipoprotein isolations were performed by cumulative flotation ultracentrifugation except in experiment B where, in addition, fractions were separated by a fixed angle technique (14) using a Beckman 40.3 rotor (Beckman Instruments Inc., Fullerton, CA). In their definitive paper on the subject, Lindgren et al. (9) described two discontinuous gradient separation systems. The first (system I), designed to fractionate lipoproteins of S > 20, was based on a NaBr gradient whose density ranged from 1.0464 to 1.006 kg/liter. In the second system, the gradient was constructed from d = 1.0988 to 1.0588 kg/liter, permitting separation of lipoproteins of Sf > 0. By use of both of these gradients, VLDL and LDL fractions of defined flotation rate could be selected at will by variation of the 2. Throughout the paper we have adopted the convention that Sf values denote lipoprotein fractions prepared by cumulative flotation. Where density intervals (e.g., d < 1.006 kg/liter) are quoted these refer to fractions prepared by anglehead ultracentrifugation. In experiment B we compared the metabolism of lipoprotein fractions isolated by cumulative flotation with that of conventional preparations made in an anglehead rotor. In the latter procedure (14) VLDL was prepared from the plasma of the fasting subjects by flotation at d < 1.006 kg/liter (40,000 rpm, 18 h, 230C in a Ti 60 rotor) and concentrated and washed by a further centrifugation at that density. After radiolabeling and injection into the donor as described below, 4.0-ml aliquots of the subject's plasma collected at various intervals were overlayered with 2.0 ml of 0.15 M NaCI/0.01% Na2 EDTA in a 40.3 rotor tube and subjected to centrifugation for 18 h at 39,000 rpm (230C). VLDL (d < 1.006 kg/liter) was removed in the top 1.0 ml of the tube. The next milliliter, which contained <4% of the total sample radioactivity, was discarded, and the remaining 4.0 ml was adjusted to d = 1.019 kg/liter by the addition of 0.48 ml of 1.182 kg/liter NaBr solution and overlayered to 6.0 ml with 1.019 kg/liter density NaBr solution. Recentrifugation for 18 h at 39,000 rpm (230C) yielded lipoproteins of d = 1.006-1.019 kg/liter in the top 1.0 ml of the tube. This was again removed carefully by aspiration, the next milliliter was discarded, and the lower 4.0 ml was increased in density and volume to 1.063 kg/liter and 6.0 ml by the addition of 2.0 ml of 1.151 kg/liter density solution. LDL (d = 1.019-1.063 kg/liter) was collected in the top 1.0 ml of the tube after centrifugation for 24 h at 39,000 rpm (230C).
Radioiodination of lipoproteins. Lipoproteins were radiolabeled by a modification (15) of the procedure of MacFarlane (16) . The material was initially concentrated to a protein content of 1-5 mg/ml by pressure filtration (XM100 filters, Amicon Corp., Lexington, MA). Labeling efficiencies for VLDL (Sf 100-400) and for lipoproteins of d < 1.006 kg/liter or Sf 20-60 were typically 5-10 and 10-20%, respectively. The amount of ICI in the reaction mixture was therefore adjusted to incorporate no more than I mol of iodine/300,000 D of protein. Free iodide was removed from the labeled lipoprotein by gel filtration through a PD 10 column (Pharmacia Fine Chemicals, London) by use of 0.15 M NaCl/0.01% Na2 EDTA (pH 7.0) as eluant. Of the material that eluted in the column void volume, >95% was precipitable with 10% trichloracetic acid. Less than 30% of the radioactivity in Sf 100-400 VLDL and 15% in the denser lipoproteins could be extracted into chloroform/methanol (1:1, vol/vol) . Approximately 40 and 70%, respectively, of the remaining protein-bound radioactivity in these fractions was precipitable with 1,1,3,3 tetramethylurea. Preliminary ultracentrifugation studies showed that the labeled lipoprotein preparations retained the ultracentrifugal characteristics of their parent lipoprotein in that >90% of their radioactivity floated within the expected density interval.
Most apoB-associated radioactivity present in the Sf 100-400 fraction comigrated upon polyacrylamide gel electrophoresis (17) with apoB 100 in LDL (Fig. 1 Plasma aliquots, taken at each time point, were collected into 0.01% Na2 EDTA and subjected to ultracentrifugation as described above to isolate the lipoproteinfractions appropriate to each experiment (see Table I ). These were stored at 4VC until the end of the collection period. The apoB present in each isolated fraction was then prepared by the tetramethylurea precipitation procedure of Kane et al. (10) , conducted at a temperature of 370C. The coefficient of variation on replicate samples was 8-12% for VLDL, IDL, and LDL apoB. In selected studies, duplicate samples were analyzed by the above tetramethylurea procedure and in parallel by the isopropanol precipitation technique of Holmqvist, Carlson, and Carlson (18) . The specific activity of the precipitated apoB did not differ significantly between the two. In the case of the normal subjects, whose VLDL (S$ 100-400) concentration was low, it was necessary to add an equivalent amount of unlabeled carrier VLDL before tetramethylurea precipitation. Radioactivity and protein measurements were made on each isolated apoBfraction as detailed elsewhere (19) . The pool size of apoB for any fraction was taken to be the mean recovered tetramethylurea precipitable protein. The apoB radioactivity in eachfraction was expressed as a percentage of the total initial B protein activity found in the 10-min plasma sample. The plasma volume was calculated as 4% of the subjects' body weights, which gave values in good agreement with those obtained from the isotope dilution that occurred over the first 10 min. apoB kinetic analysis. The algorithm proceeded as follows. The program input parameters were: (a) time of sampling; (b) observed apoB radioactivities expressed as a fraction of the total apoB radioactivity present in the 10-min sample; (c) a weight for each datum calculated from its estimated error; and (d) initial estimates for the rate parameters described in the models (Figs. 3, 4, and 8 ). An iterative procedure adjusted the rate constants to minimize the sum of squares between observed and calculated data. The final solution was accepted when it gave a consistent and unique fit to the data (31) .
Sf 100-400 flotation range and accumulated rapidly in an Sf 12-100 species, which became maximally labeled within 5 h. The biexponential clearance of activity from this intermediate fraction suggested that it contained at least two metabolically distinct components, reflected in the two pool system (pools 3 and 4, Fig. 3 ) which was required to achieve an acceptable computer fit of the data. The subsequent appearance of radioactivity in Sf 0-12 lipoproteins, which increased progres- Vy sively for 24 h after the injection, indicated that at least a fraction of the apoB in the intermediate species was being transferred into LDL. The terminal clearance of LDL apoB radioactivity was slow (Fig. 2) and could be adequately represented by a single pool in equilibrium with an extravascular compartment (Fig. 3) . The rates of exchange between these compartments was limited to maintain 72% of LDL in the plasma in accordance with values obtained from studies of LDL kinetics (see reference 20). Overall, the form of the plasma apoB clearance curves was similar in the normal and hypertriglyceridemic individuals. The rate constants that were derived from them by multicompartmental computer analysis are given in Table II Fig. 5 and Tables III and IV . Fig. 5 a shows that apoB radioactivity in the injected Sf 100-400 tracer was transferred only partially to the d = 1.006-1.019 kg/liter fraction and from there to LDL. Indeed, the peak value for LDL (-8-9% of the initial plasma apoB radioactivity) in these three individuals was on a similar order to that found in the Sf 0-12 fraction of the control subjects (-6%) in experiment A. Conversely, the apoB injected in VLDL of d < 1.006 kg/ liter, which had been prepared by anglehead centrifugation, was rapidly and substantially transferred through the d = 1.006-1.019 kg/liter intermediate fraction to LDL (Fig. 5 b) . Table  IV describes the net transfer of radioactivity into LDL as a percentage of that initially associated with VLDL apoB. It can (Fig. 7 b) The kinetic parameters of apoB in VLDL of Sf 100-400 and 20-60 for subject HTG5 are included for comparison (Table VI) . The clearance rate of his Sf 100-400 apoB was similar to that observed in the other hypertriglyceridemic subjects. Again, the fractional catabolism of Sf 20-60 VLDL apoB derived from S$ 100-400 material was substantially slower than that of the directly labeled lipoprotein (compare 0.04 with 0.164 pools/h in Table VI ). The plasma concentrations of apoB present in each flotation interval are provided for reference in Table VII . It is evident that in the dysbetalipoproteinemic subjects the apoB mass distribution favors the small Sf 20-60 VLDL fraction. A more complete comparison of the physical and chemical properties of these lipoprotein classes has been presented elsewhere (I 1).
Discussion
The apoB-containing lipoproteins VLDL Fig. 3 . In this study radioactive label was introduced into compartment 3, i.e., the first compartment in the intermediate lipoprotein range. The estimated rate constants describe the movement of apoB radioactivity from the entire Sf 12-100 range into Sf 0-12.
to show substantial variation in their physicochemical properties. It seems appropriate now to consider the likelihood that metabolic heterogeneity accompanies this structural diversity. This question is addressed in the present study. Early metabolic investigations of the conversion of VLDL to LDL relied heavily on anglehead centrifugation for fractionation of the lipoprotein species. The results indicated that the apoB component of VLDL (d < 1.006 kg/liter) was transferred virtually quantitatively into the LDL density range (d = 1.006-1.063 kg/liter) in normal subjects (1), but incompletely in hypertriglyceridemics (2, 19) . A second generation of studies dissected out a transient intermediate in this process of nominal density 1.006-1.019 kg/liter, which seemed to conserve all apoB from VLDL but transmit only a fraction of it into LDL, even in normal individuals (5, 6) . In addition, it became clear that input of apoB into the VLDL -LDL cascade could occur at multiple sites, indicating that particles of different H O U R composition were being secreted continuously into what was originally considered to be a single pool (4, 22) . In order to calculate B protein flux rates it had to be assumed that such particles become almost instantaneously metabolically identical.
However, as Fisher (22) The investigation of metabolic heterogeneity among lipoproteins is critically dependent on the ability of the chosen fractionation procedure to separate particles with defined physicochemical properties. The cumulative flotation procedure described by Lindgren et al. (9) offers such a possibility. Manipulation of the centrifugal conditions permits selection at will of clearly delineated lipoprotein fractions. This therefore offers significant advantages over the anglehead ultracentrifugation procedure. In experiment B we found that the amount of apoB radioactivity that appeared in what was nominally LDL depended on the choice of centrifugation procedure. Fig.  9 exemplifies the point. Here we examine the transfer of radioactivity from VLDL apoB of d < 1.006 kg/liter into LDL prepared (a) as 1.019-1.063 kg/liter lipoprotein by anglehead separation, or (b) as the Sf 0-12 fraction by cumulative flotation. Both of these procedures, in theory, should isolate the same LDL fraction. However, it is clear that the anglehead technique results in a higher apparent conversion than the cumulative flotation approach (Table IV) . We believe that the standard conditions applied to the anglehead separation (i.e., 40,000 rpm in a 40.3 rotor for up to 24 h [5, 6] ) inadequately clear all lipoproteins of Sf > 12 from LDL in the infranatant. This proposal is supported by the observation that increasing the solute density in the anglehead rotor to 1.025 kg/liter (23) reduces the transfer of radioactivity into LDL towards the value obtained by cumulative flotation (Fig. 9) . In three separate reports (23) (24) (25) it has been observed that LDL (d = 1.019-1.063 kg/liter) isolated in the anglehead rotor under the conditions described above was contaminated with intermediate lipoprotein of d < 1.020 kg/liter which could be 2188 (1, 2, 6, 19) . However, as indicated above, this ignores the problem of metabolic channeling. The true flux rates can only be determined from a knowledge of the size and catabolic rate of the individual apoB subcompartments in VLDL.
In experiment C we attempted to examine more closely the particle distribution in the VLDL subcompartments. We predicted that VLDL of Sf 40-60 would probably be enriched in lipoproteins derived by catabolism of large triglyceride-rich particles (Sf 100-400) whereas direct particle synthesis into the Sf 12-100 range would favor the smaller VLDL (Sf 20-40). If this assumption is correct, on the basis ofthe previous argument, the Sf 20-40 lipoproteins should transit more rapidly and completely into LDL than would the larger Sf 40-60 particles. Fig. 6 shows that our prediction was correct. So, even these VLDL particles with similar flotation rates are substantially different in their metabolic behavior. However, it must be remembered that particles of Sf 20 (diameter -300 A) have only one third (10, 11) of the volume of Sf 60 particles (diameter 450 A). This size difference allows for substantial underlying structural variability to account for the observed metabolic heterogeneity.
In the final series of studies (experiment D) we followed apoB metabolism in Type III hyperlipoproteinemic subjects in an attempt to locate more accurately the lesion in apoB metabolism that accompanies this phenotype. We found that the conversion of large VLDL (Sf 100-400) to smaller particles in the Sf 20-60 flotation range was normal. This is consonant with the knowledge that lipoprotein lipase levels in Type III hyperlipoproteinemic subjects are normal (26 plasma than is apoB,00. So it is not surprising that the Sf 100-400 VLDL from a Type IV subject, who does not accumulate chylomicrons or their remnants, is catabolized virtually monoexponentially when injected into subject DyS#3 (Fig. 7 c) .
Although these putative chylomicron remnants accumulate in Type III plasma, they are not the only slowly metabolized species in the Sf > 20 VLDL. ApoB that has transferred in an apparently normal way from larger triglyceride-rich VLDL lingers in the Sf 20-60 range, suggesting that further processing Figure 9 . The disappearance of apoB radioactivity injected in Sf 100400 VLDL and reisolated from the d < 1.006 kg/liter density interval. The appearance of this radioactivity in the intervals 1.019-1.063 and 1.025-1.063 kg/liter and S 0-12 is shown above. The data here are from subject N7. Note that for the sake of clarity the curve representing apoB radioactivity in Sr 12-20 lipoproteins has been omitted from the figure. of these VLDL remnants is blocked by the metabolic defect. But these remnants apparently constitute only a fraction of the S$ 20-60 lipoproteins. When the latter are isolated and labeled directly, most exhibit relatively rapid plasma clearance into particles of Sf 12-20 (Fig. 7 b) . These individuals therefore also seem to have at least two metabolically distinct small VLDL particle types. The weight of evidence presented in this study suggests that chemical equilibrium and therefore metabolic homogeneity is not a feature of VLDL turnover. The ultimate fate of any particular particle depends on its pedigree. In both normal and hypertnglyceridemic subjects there appear to be within 
